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Abstract
Introduction: Primary mantle cell lymphoma of the esophagus is quite rare, and we report here
a case of a submucosal polypoid tumor of the esophagus that was pathologically similar, but not
identical, to mantle cell lymphoma.
Case presentation: A 66-year-old man underwent surgery in our hospital for a submucosal tumor
of the esophagus. Histopathologically, the submucosal tumor uniformly showed a vague, nodular
pattern composed of a regular proliferation of CD3-CD10-CD20+CD79a+bcl2+ small lymphoid
cells with islands of abortive CD10+Ki67+ germinal centers, without evidence of marginal zone
formation or lymphoepithelial lesions. These features were consistent with mantle cell lymphoma.
However, the proliferating cells weakly expressed the D-type cyclins, IgD and IgM. The tumor was
diagnosed as a “mantle cell lymphoma-like tumor”. Postoperative examination confirmed no tumour
involvement in other organs. The patient was treated with rituximab postoperatively and has been
disease free for more than 28 months after surgery.
Conclusion: The present case might be regarded as a “hyperplastic change of the mantle zone”
without the molecular features of mantle cell lymphoma, a case that adds to the limited
clinicopathological data on B-lymphoproliferative diseases of the esophagus.
Introduction
The esophagus is the least common site of involvement of
lymphomainthedigestivetract,accountingforlessthan1%
of lymphoma patients. Primary esophageal lymphomas are
usually large B-cell types or low-grade B-cell mucosa-
associated lymphoid tissue (MALT) [1]. Furthermore,
primary mantle cell lymphoma (MCL) of the esophagus
hasnotbeenreported,onlyacaseofMCLarisinginBarrett’s
dysplasia[2].Herewereportanesophagealpolypoidtumor
that resembles MCL but lacks critical MCL features.
Case presentation
A 66 year-old Japanese male underwent upper gastro-
intestinal endoscopy by his practitioner for complaints of
dysphagia, which revealed an esophageal submucosal
tumor. He was referred to the National Hospital
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He did not complain of fever, weight loss, or night
sweating. On admission, physical examination revealed
no remarkable features; the liver, spleen, and superficial
nodes were not palpable. His laboratory data showed no
abnormalities except a 10-year history of abnormal
glucose tolerance treated by his primary physician. No
elevated tumor markers or autoimmune antibodies were
observed. A barium esophagogram, CT, and upper GI
endoscope showed an esophageal submucosal polypoid
lesion at the cervical esophagus (Figure 1). Its location
close to the esophageal orifice and large size (4 × 2 cm)
made an endoscopic resection technically difficult, and the
patient was enrolled in the Department of Surgery. As the
tumor was endoscopically diagnosed as benign leio-
myoma or lipoma, we decided to perform a tumor
resection because of the patient’s complaints of dysphagia
and because the cervical esophagus is relatively approach-
able compared with the thoracic esophagus, even with-
out pathological diagnosis. The tumor was removed
through a cervical esophagotomy under a cervical collar
incision.
The tumor macroscopically showed a submucosal poly-
poid appearance (Figure 2A). Resected tissue was fixed in
20% formalin, embedded in paraffin, and routinely
stained with hematoxylin and eosin, followed by
immunohistochemical analyses with monoclonal anti-
bodies, as summarized in Table 1 (supplement). The
tumor was composed of multiple, vague nodules (Figure
2A, 2B) that contained abortive CD10+Ki67+ germinal
centers surrounded by a regular proliferation of CD3-
CD20+CD79a+ bcl2+ small lymphoid cells without
immunoblastic large cells (Figure 2C). These areas
corresponded to the mantle zone, with no definite
formation of the marginal zone observed. No lymphoe-
pithelial lesions (intraepithelial infiltration of neoplastic
B-cells with architectural distortion of epithelial struc-
tures) were observed, but it showed a typical mantle cell
pattern, which was further supported by a sparse
distribution of CD21+ follicular dendritic cells (FDCs)
next to a dense distribution of FDC in the germinal centers
(Figure 3) and negativity for MUM1 protein (approxi-
mately 1%, data not shown) [3]. We then examined the
chromosomal rearrangement involving IgH and Bcl1 by
fluorescence in situ hybridization. In brief, DNA was
hybridized with Vysis
“ LSI
“ IGH/CCND1 Rearrangement
probes (ABBOTT, Wiesbaden, Germany), as described
previously [4]. The IgH-BclI chimera was observed in only
1% of examined cells (2.8%, with 0.8% standard
Figure 1. Preoperative examinations. An esophageal submucosal polypoid lesion was identified by barium esophagogram (A),
CT (B), and downward (C, left) and upward (C, right) views by upper GI endoscope. Arrows indicate the tumor at the cervical
esophagus.
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stained for cyclin D1, D2, or D3 only sporadically (1–2%)
without expressing IgD or IgM (data not shown). We
noted infiltration by CD5+ T cells, but the majority of
proliferating cells were negative for CD5 (Figure 3). This
pattern was also similar to the mantle zone of the normal
lymphoid tissue (Figure 3).
The patient experienced a good post-operative course, and
was enrolled in the Department of Hematology. Lym-
phoma metastasis was evaluated by a whole body CT scan,
PET-CT, bone marrow examination, Ga-scintigram, and
total colonoscopy, but no other sites were involved. The
diagnosis was stage IAE, and rituximab was given as
adjuvant chemotherapy. This patient has been disease free
for more than 28 months after surgery.
Discussion
Primary esophageal lymphoma is rare, with no MCL
reported except a case in cardiac-type glandular tissue
replacement of the lower esophagus [1, 2, 5–7]. This case,
reported by Reyes, contains the typical molecular features
of MCL, CD5 staining, cyclin D1 staining, and chromo-
somal translocation [t(11;14)(q13;q32)] [2]. However,
this case arose in cardiac-type glandular tissue replacing
the lower oesophagus, not in squamous epithelial tissue.
Furthermore, MCL could have originated in the herniated
subcardial region of the stomach, because the diagnosis
was obtained from biopsies and the presence of a proper
esophageal gland was not confirmed.
MALT lymphoma can arise in the esophagus. Hosaka and
colleagues showed that three cases previously reported as a
Figure 2. Resected specimen. Macroscopic appearance of the tumor (A), low magnification of the polypoid lesion (B),
and microscopic image of atypical lymphoid cells (C). Vague nodules with an abortive germinal center are indicated by arrows.
Scale bar = 1 mm (B). Regular small lymphoid cells surrounding abortive germinal centers. Scale bar = 50 mm (C).
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Antibodies for Spieces Sources Clones Final dilution Heat antigen retreival
CD3 mouse Mab Dako F7.2.38 1:40, 6 mg/ml T/E, 95C, 60 min
CD5 mouse Mab Novocastra 4C7 1:100 T/E, 95C, 60 min
CD10 mouse Mab Novocastra 56C6 1:100 T/E, 95C, 60 min
CD20 mouse Mab Dako L26 1:400, 1 mg/ml none
CD21 mouse Mab Dako 1F8 1:50, 7 mg/ml Dako S1700, 95C, 60min
CD79a mouse Mab Nichirei JCB117 1:150 T/E, 95C, 60 min
bcl-2 mouse Mab Dako 124 1:100, 2.6 mg/ml T/E, 95C, 60 min
MUM1 protein mouse Mab Dako MUM1p 1:100, 7.5 mg/ml T/E, 95C, 60 min
cyclin D1 rabbit Mab Nichirei SP4 1:25 T/E, 95C, 60 min
cyclin D2 rabbit Pab Santa Cruz (sc-593) 1:100, 2ug/ml T/E, 95C, 60 min
cyclin D3 mouse Mab Progen DCS-22 undiluted T/E, 95C, 60 min
IgD rabbit Pab Dako A0093 1:1500 RT, 30 min
Mab, monoclonal antibody. Pab, polyclonal antibody. RT, room temperature T/E, 10mM Tris HCl buffer/1mM EDTA, pH9.0 Dako, Glustrup, Denmark.
Novocastra, Benton Lane, UK. Nichirei, Tokyo, Japan. Santa Cruz Biotechnology, Santa Cruz, CA. Progen Biotechnik, Heidelberg, Germany.
Figure 3. Immunohistochemical analyses of the tumor. CD20-positive lymphoid cells surround abortive CD10-positive germinal
centers. Scale, 200 mmo r5 0mm, is indicated by bars in CD20 or CD10, respectively. About 10-20% of proliferating cells were
CD5 positive lymphoid cells (T-cells), but the vast majority were not. CD21-positive follicular dendritic cells were structurally
aligned around germinal centers. The germinal center is indicated by GC and dotted circles with a scale bar of 50 mm.
Immunohistochemical analyses by cyclin D1, with a scale bar of 50 mm.
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lymphomas [1]. The differential diagnosis of malignant
lymphoma could improve with endoscopic mucosal
resection, which obtains a greater amount of tissue than
conventional biopsies. Our case showed recurring pro-
liferation of small lymphocytes, but no large cells,
surrounding abortive germinal centers. This indicates
proliferation of the mantle zone but not the marginal
zone. For differential diagnosis, we first need to consider
extranodal marginal zone lymphoma (MALT lymphoma).
However, the marginal zone typically seen in MALT
lymphoma was not present here [1], nor was there a
lymphoepithelial lesion. Therefore, we excluded MALT
lymphoma. We also need to consider Castleman disease,
which includes a hyaline vascular type and a plasma cell
type [8, 9]. The germinal center here lacked the character-
istic vasculature with a hyalinized wall, and plasma cell
infiltration was not observed in the whole areas. These
pathological findings prompted us to exclude Castleman's
disease.
Although this case resembled MCL, it lacked the immu-
nostaining and molecular features typical for MCL,
including weak expression of cyclins D1, D2, D3, CD5,
IgD, or IgM. According to the WHO classification 4
th
edition, cyclin-D1-negative MCL should overexpress cyclin
D2 or D3, as confirmed by gene expression profiles [10].
In addition, MCL prognosis is not favourable, with thevast
majority of MCL patients not curable long-term [11].
The current case has been disease free for more than
28 months, suggesting that this case clinically does not fit
typical MCL.
Conclusion
Taken together, the current case has similar histological
features to MCL, but does not fit the MCL diagnosis. The
present case may be “hyperplasia of the mantle zone
without neoplastic transformation,” but this conclusion
would require careful follow-up. We also need further
clinicopathological data regarding B-cell lymphomas of
the esophagus.
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